Molina Healthcare Reports Fourth Quarter and Year-End 2020 Financial Results

Introduces Full Year 2021 Earnings Guidance

LONG BEACH, Calif.--()--Molina Healthcare, Inc. (NYSE: MOH) today reported net income for the fourth quarter of 2020 of $34 million, or $0.56 per diluted share, and $673 million, or $11.23 per diluted share, for the full year 2020. Financial results are summarized below:

 

Three Months Ended

 

Year Ended

 

December 31,

 

December 31,

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

 

 

 

(In millions, except per share results)

Premium Revenue

$4,855

 

 

$4,123

 

 

$18,299

 

 

$16,208

 

Total Revenue

$5,235

 

 

$4,274

 

 

$19,423

 

 

$16,829

 

Pre-Tax Income

$51

 

 

$222

 

 

$961

 

 

$972

 

Net Income

$34

 

 

$168

 

 

$673

 

 

$737

 

GAAP EPS – Diluted

$0.56

 

 

$2.67

 

 

$11.23

 

 

$11.47

 

Adjusted EPS – Diluted (1)

($0.51)

 

 

$2.73

 

 

$10.67

 

 

$11.57

 

Normalized EPS - Diluted (1)

$3.29

 

 

 

 

$12.97

 

 

 

 

GAAP Ratios:

 

 

 

 

 

 

 

 

 

 

MCR

90.8

%

 

 

86.0

%

 

 

86.5

%

 

 

85.8

%

G&A Ratio

8.6

%

 

 

8.0

%

 

 

7.6

%

 

 

7.7

%

Effective Tax Rate

33.8

%

 

 

24.3

%

 

 

30.0

%

 

 

24.2

%

After-Tax Margin

0.6

%

 

 

3.9

%

 

 

3.5

%

 

 

4.4

%

 
(1) Description and reconciliation of non-GAAP financial measures on pages 11-12 of this release.

Full Year Highlights

  • Total revenue increased 15% to $19.4 billion for the full year 2020 compared to 2019.
  • For the full year 2020, net income was $673 million, or $11.23 per diluted share, compared to net income of $737 million, or $11.47 per diluted share, for the full year 2019.
  • Results were positively impacted by adjustments of $0.56 per diluted share for the full year 2020.
  • The net effect of COVID decreased net income for the full year 2020 by $2.30 per diluted share.
  • Full year 2020 normalized EPS, representing adjusted EPS and excluding the net effect of COVID, was $12.97 per diluted share.
  • The Company issued its full year 2021 earnings guidance, with premium revenue growth expected to be over 25% and adjusted EPS expected to be in the range of $12.50 - $13.00.
  • Included in the Company’s guidance is the effect of the overhang from COVID and Medicare risk scores expected to soon abate. When combined with the attainment of targeted margins on recent acquisitions, the Company expects an increase of several dollars in EPS in future periods.

“2020 presented an unprecedented environment, and I am proud of our performance as we focused on delivering for all of our stakeholders. We ensured our members had access to high quality care, we implemented innumerable special protocols for providers and our state customers, and we delivered growth and excellent financial results,” said Joseph Zubretsky, president and CEO of Molina Healthcare. “As the pandemic continues into 2021, we are determined to do the same. We are pleased with the significant revenue growth we expect to achieve in 2021, and look forward to another successful year.”

Total Revenue

For the year ended December 31, 2020, total revenue increased 15% to $19.4 billion, compared to $16.8 billion for the comparable period in 2019. The higher total revenue reflects increased membership, primarily in Medicaid, and includes the impact from the YourCare and Passport acquisitions.

Net Income

For the year ended December 31, 2020, net income was $673 million, or $11.23 per diluted share, compared to net income of $737 million, or $11.47 per diluted share, for the full year 2019.

For the full year 2020, the Company’s normalized EPS was $12.97 and normalized after-tax margin was 3.9%. The Company’s results were positively impacted by adjustments of $0.56 per diluted share for the full year 2020. The Company estimates the net effect of COVID decreased full year 2020 GAAP EPS by $2.30 per diluted share.

Medical Care Ratio

The consolidated MCR for the year ended December 31, 2020, was 86.5%, compared to 85.8% for 2019. The full year 2020 normalized MCR, which excludes adjustments and the net effect of COVID, was 85.9%. Medicaid and Medicare performed in line with expectations, while Marketplace performance was below expectations.

General and Administrative Expense Ratio

For the year ended December 31, 2020, the G&A ratio was 7.6% compared to 7.7% in 2019. The full year 2020 normalized G&A ratio, which excludes adjustments and the net effect of COVID, was 7.3%. This improvement reflects disciplined cost management and the benefits of scale produced by the Company’s growth.

Balance Sheet

Cash and investments at the parent company amounted to $644 million as of December 31, 2020, compared to $997 million as of December 31, 2019. In November 2020, the Company closed on its private offering of $650 million aggregate principal amount of 3.875% senior notes due November 15, 2030. The Company used a portion of the proceeds to repay $330 million principal amount outstanding of its 4.875% senior notes.

In September 2020, the Company’s Board of Directors authorized a share repurchase program of up to $500 million. Through December 31, 2020, the Company purchased an aggregate of approximately 766,000 shares for $159 million, at an average cost of $208.37 per share.

Cash Flow

Operating cash flow for the year ended December 31, 2020, amounted to $1,890 million, and was higher compared to the year ended December 31, 2019, primarily due to strong operating results, cash flow timing benefits from the growth in membership in 2020, and the net impact of timing differences in governmental receivables and payables.

2021 Guidance

The Company issued its full year 2021 earnings guidance, with premium revenue growth expected to be over 25% and adjusted EPS expected to be in the range of $12.50 - $13.00. Given its recent M&A activity and the associated non-cash impact from amortization of intangible assets, the Company believes that adjusted EPS has become a more relevant measure of earnings going forward.

Full year guidance reflects the following expected positive drivers:

  • Continued strong performance in Medicaid and Medicare;
  • Margin recovery and growth in the Marketplace business;
  • Accretion from the Magellan Complete Care businesses and the Kentucky and Passport installation; and,
  • The elimination of the Health Insurer Fee.

Full year guidance considers the following industry-wide and economic environment challenges that are expected to be mostly temporary, including:

  • A negative net effect of COVID due to a continuation of many of the risk-sharing corridors that existed in 2020 and the direct costs of COVID-related patient care;
  • Medicare risk scores; and,
  • Net pharmacy benefit carve-outs.

Full year guidance does not include:

  • The Affinity acquisition, as the transaction has not yet closed; and,
  • The impact of potential Public Health Emergency extensions beyond mid-April 2021.

Included in the Company’s guidance is the effect of the overhang from COVID and Medicare risk scores expected to soon abate. When combined with the attainment of targeted margins on recent acquisitions, the Company expects an increase of several dollars in EPS in future periods.

The Company has posted a presentation entitled “4Q20 Earnings Supplement,” dated February 10, 2021, on the Company’s website, molinahealthcare.com.

Full Year 2021 Guidance (1)

Premium Revenue

>$23.0B

Total Revenue

>$24.0B

GAAP Net Income

$649M - $678M

Adjusted Net Income (2)

$730M - $759M

GAAP EPS – Diluted

$11.10 - $11.60

Adjusted EPS – Diluted (2)

$12.50 - $13.00

Diluted weighted average shares

~58.5M

 

 

Year End Total Membership

~3.9M

Medicaid and Medicare

~3.5M

Marketplace

~400K

 

 

MCR

~88.0%

GAAP G&A Ratio

~7.3%

Adjusted G&A Ratio (2)

~7.0%

Effective Tax Rate

~25.6%

GAAP After-tax Margin

~2.7%

Adjusted After-tax Margin (2)

~3.0%

 

(1) All amounts are rounded and approximations.

(2) Reconciliations of non-GAAP financial measures on page 13 of this release.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s fourth quarter and year-end 2020 results at 8:00 a.m. Eastern Time on Thursday, February 11, 2021. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 9566162. A telephonic replay of the conference call will be available through Thursday, February 18, 2021, by dialing (877) 344-7529 and entering confirmation number 10150614. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 4.0 million members as of December 31, 2020. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements regarding its 2021 guidance, as well as its plans, expectations, and the Company’s expectations regarding future developments. Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, and also in its Quarterly Reports on Form 10-Q for the periods ended March 31, 2020, June 30, 2020, and September 30, 2020, which are on file with the SEC. Additional information will also be set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, which the Company expects to file on or about February 12, 2021.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of February 10, 2021, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

MOLINA HEALTHCARE, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

 

 

 

 

 

Three Months Ended

 

Year Ended

 

December 31,

 

December 31,

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

 

 

 

(In millions, except per-share amounts)

Revenue:

 

 

 

 

 

 

 

Premium revenue

$

4,855

 

 

$

4,123

 

 

$

18,299

 

 

$

16,208

 

Premium tax revenue

172

 

 

122

 

 

649

 

 

489

 

Health insurer fees reimbursed

65

 

 

 

 

271

 

 

 

Marketplace risk corridor judgment

128

 

 

 

 

128

 

 

 

Investment income and other revenue

15

 

 

29

 

 

76

 

 

132

 

Total revenue

5,235

 

 

4,274

 

 

19,423

 

 

16,829

 

Operating expenses:

 

 

 

 

 

 

 

Medical care costs

4,408

 

 

3,545

 

 

15,820

 

 

13,905

 

General and administrative expenses

450

 

 

343

 

 

1,480

 

 

1,296

 

Premium tax expenses

172

 

 

122

 

 

649

 

 

489

 

Health insurer fees

68

 

 

 

 

277

 

 

 

Depreciation and amortization

24

 

 

21

 

 

88

 

 

89

 

Other

22

 

 

1

 

 

31

 

 

6

 

Total operating expenses

5,144

 

 

4,032

 

 

18,345

 

 

15,785

 

Operating income

91

 

 

242

 

 

1,078

 

 

1,044

 

Other expenses, net:

 

 

 

 

 

 

 

Interest expense

30

 

 

20

 

 

102

 

 

87

 

Other expense (income), net

10

 

 

 

 

15

 

 

(15)

 

Total other expenses, net

40

 

 

20

 

 

117

 

 

72

 

Income before income tax expense

51

 

 

222

 

 

961

 

 

972

 

Income tax expense

17

 

 

54

 

 

288

 

 

235

 

Net income

$

34

 

 

$

168

 

 

$

673

 

 

$

737

 

 

 

 

 

 

 

 

 

Net income per share - Diluted

$

0.56

 

 

$

2.67

 

 

$

11.23

 

 

$

11.47

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

59.4

 

 

63.0

 

 

59.9

 

 

64.2

 

 

 

 

 

 

 

 

 

Operating Statistics:

 

 

 

 

 

 

 

Medical care ratio

90.8

%

 

86.0

%

 

86.5

%

 

85.8

%

G&A ratio

8.6

%

 

8.0

%

 

7.6

%

 

7.7

%

Premium tax ratio

3.4

%

 

2.9

%

 

3.4

%

 

2.9

%

Effective income tax rate

33.8

%

 

24.3

%

 

30.0

%

 

24.2

%

After-tax margin

0.6

%

 

3.9

%

 

3.5

%

 

4.4

%

MOLINA HEALTHCARE, INC.

CONSOLIDATED BALANCE SHEETS

 

 

 

December 31,

 

2020

 

2019

 

Unaudited

 

 

 

(Dollars in millions,
except per-share amounts)

ASSETS

Current assets:

 

 

 

Cash and cash equivalents

$

4,154

 

 

$

2,452

 

Investments

1,875

 

 

1,946

 

Receivables

1,672

 

 

1,406

 

Prepaid expenses and other current assets

175

 

 

163

 

Total current assets

7,876

 

 

5,967

 

Property, equipment, and capitalized software, net

391

 

 

385

 

Goodwill and intangible assets, net

941

 

 

172

 

Restricted investments

136

 

 

79

 

Deferred income taxes

69

 

 

79

 

Other assets

119

 

 

105

 

Total assets

$

9,532

 

 

$

6,787

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

Medical claims and benefits payable

$

2,696

 

 

$

1,854

 

Amounts due government agencies

1,253

 

 

664

 

Accounts payable, accrued liabilities and other

641

 

 

502

 

Deferred revenue

375

 

 

249

 

Total current liabilities

4,965

 

 

3,269

 

Long-term debt

2,127

 

 

1,237

 

Finance lease liabilities

225

 

 

231

 

Other long-term liabilities

119

 

 

90

 

Total liabilities

7,436

 

 

4,827

 

Stockholders’ equity:

 

 

 

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million shares at December 31, 2019

 

 

 

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

 

 

 

Additional paid-in capital

199

 

 

175

 

Accumulated other comprehensive income

37

 

 

4

 

Retained earnings

1,860

 

 

1,781

 

Total stockholders’ equity

2,096

 

 

1,960

 

Total liabilities and stockholders’ equity

$

9,532

 

 

$

6,787

 

 

 

 

 

MOLINA HEALTHCARE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

Year Ended

 

December 31,

 

2020

 

2019

 

 

 

 

 

(In millions)

Operating activities:

 

 

 

Net income

$

673

 

 

$

737

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

88

 

 

89

 

Deferred income taxes

(19)

 

 

10

 

Share-based compensation

57

 

 

39

 

Loss (gain) on debt repayment

15

 

 

(15)

 

Other, net

12

 

 

 

Changes in operating assets and liabilities:

 

 

 

Receivables

(100)

 

 

(76)

 

Prepaid expenses and other current assets

(16)

 

 

28

 

Medical claims and benefits payable

544

 

 

(107)

 

Amounts due government agencies

446

 

 

(303)

 

Accounts payable, accrued liabilities and other

78

 

 

2

 

Deferred revenue

126

 

 

38

 

Income taxes

(14)

 

 

(15)

 

Net cash provided by operating activities

1,890

 

 

427

 

Investing activities:

 

 

 

Purchases of investments

(670)

 

 

(2,536)

 

Proceeds from sales and maturities of investments

1,097

 

 

2,302

 

Net cash paid in business combinations

(755)

 

 

 

Purchases of property, equipment, and capitalized software

(74)

 

 

(57)

 

Other, net

2

 

 

(2)

 

Net cash used in investing activities

(400)

 

 

(293)

 

Financing activities:

 

 

 

Proceeds from senior notes offerings, net of issuance costs

1,429

 

 

 

Common stock purchases

(606)

 

 

(47)

 

Repayment of term loan facility

(600)

 

 

 

Proceeds from borrowings under term loan facility

380

 

 

220

 

Repayment of senior notes

(338)

 

 

 

Cash paid for partial termination of warrants

(30)

 

 

(514)

 

Cash paid for partial settlement of conversion option

(27)

 

 

(578)

 

Cash received for partial settlement of call option

27

 

 

578

 

Repayment of principal amount of convertible senior notes

(12)

 

 

(240)

 

Other, net

2

 

 

29

 

Net cash provided by (used in) financing activities

225

 

 

(552)

 

Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents

1,715

 

 

(418)

 

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

2,508

 

 

2,926

 

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

$

4,223

 

 

$

2,508

 

MOLINA HEALTHCARE, INC.

UNAUDITED HEALTH PLANS SEGMENT DATA

(Dollars in millions)

 

 

 

As of December 31,

 

2020

 

2019

Ending Membership(1) by Government Program:

 

 

 

Medicaid

3,599,000

 

 

2,956,000

 

Medicare

115,000

 

 

101,000

 

Marketplace

318,000

 

 

274,000

 

Total

4,032,000

 

 

3,331,000

 

 

 

 

 

Ending Membership(1) by Health Plan:

 

 

 

California

593,000

 

 

565,000

 

Florida

140,000

 

 

132,000

 

Illinois

302,000

 

 

224,000

 

Kentucky

337,000

 

 

 

Michigan

400,000

 

 

362,000

 

Ohio

352,000

 

 

288,000

 

Texas

357,000

 

 

341,000

 

Washington

977,000

 

 

832,000

 

Other (2)

574,000

 

 

587,000

 

Total

4,032,000

 

 

3,331,000

 

__________________

(1) Does not include approximately 200,000 Magellan Complete Care members from the acquisition closed on December 31, 2020.

(2) “Other” includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah, and Wisconsin health plans, which were not individually significant to the Company’s consolidated operating results for the periods presented.

 

Three Months Ended December 31,

 

2020

 

2019

 

Premium
Revenue

 

Medical
Care Costs

 

MCR (1)

 

Premium
Revenue

 

Medical
Care Costs

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

3,850

 

 

$

3,473

 

 

90.2

%

 

$

3,227

 

 

$

2,818

 

 

87.3

%

Medicare

616

 

 

598

 

 

97.1

 

 

561

 

 

480

 

 

85.5

 

Marketplace

389

 

 

337

 

 

86.6

 

 

335

 

 

247

 

 

73.5

 

Consolidated

$

4,855

 

 

$

4,408

 

 

90.8

%

 

$

4,123

 

 

$

3,545

 

 

86.0

%

 

Year Ended December 31,

 

2020

 

2019

 

Premium
Revenue

 

Medical
Care Costs

 

MCR (1)

 

Premium
Revenue

 

Medical
Care Costs

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

14,265

 

 

$

12,461

 

 

87.4

%

 

$

12,466

 

 

$

10,969

 

 

88.0

%

Medicare

2,512

 

 

2,161

 

 

86.0

 

 

2,243

 

 

1,913

 

 

85.3

 

Marketplace

1,522

 

 

1,198

 

 

78.7

 

 

1,499

 

 

1,023

 

 

68.2

 

Consolidated

$

18,299

 

 

$

15,820

 

 

86.5

%

 

$

16,208

 

 

$

13,905

 

 

85.8

%

__________________

(1) The MCR represents medical costs as a percentage of premium revenue.

MOLINA HEALTHCARE, INC.
CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

 

Year Ended

 

December 31,

 

2020

 

2019

 

 

 

 

 

Unaudited

Medical claims and benefits payable, beginning balance

$

1,854

 

 

$

1,961

 

Components of medical care costs related to:

 

 

 

Current year

15,939

 

 

14,176

 

Prior year

(119)

 

 

(271)

 

Total medical care costs

15,820

 

 

13,905

 

Payments for medical care costs related to:

 

 

 

Current year

13,871

 

 

12,554

 

Prior year

1,507

 

 

1,482

 

Total paid

15,378

 

 

14,036

 

Acquisition - Magellan Complete Care

294

 

 

 

Change in non-risk and other provider payables

106

 

 

24

 

Medical claims and benefits payable, ending balance

$

2,696

 

 

$

1,854

 

 

 

 

 

Days in claims payable, fee for service (1)

50

 

 

50

 

______________________

(1) Claims payable includes primarily claims incurred but not paid, or IBNP. It also includes certain fee-for-service payables reported in medical claims and benefits payable amounting to $78 million and $50 million, as of December 31, 2020, and 2019, respectively.

MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES
(In millions)

The Company believes that certain non-generally accepted accounting principles, or non-GAAP, financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

Earnings before interest, taxes, depreciation and amortization (“EBITDA”) represents GAAP net income less depreciation and amortization, interest expense and income tax expense. The Company believes that EBITDA is helpful to investors in assessing the Company’s ability to meet the cash demands of its operating units.

 

Three Months Ended

 

Year Ended

 

December 31,

 

December 31,

 

2020

 

2019

 

2020

 

2019

Net income

$

34

 

 

$

168

 

 

$

673

 

 

$

737

 

Adjustments:

 

 

 

 

 

 

 

Depreciation and amortization

24

 

 

21

 

 

88

 

 

89

 

Interest expense

30

 

 

20

 

 

102

 

 

87

 

Income tax expense

17

 

 

54

 

 

288

 

 

235

 

EBITDA

$

105

 

 

$

263

 

 

$

1,151

 

 

$

1,148

 

 

 

 

 

 

 

 

 

MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES CONTINUED
(In millions, except per diluted share amounts)

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of purchased intangibles and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted net income (loss) represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

Adjusted net income (loss) per diluted share represents adjusted net income (loss) divided by weighted average common shares outstanding on a fully diluted basis.

 

Three Months Ended December 31,

 

Year Ended December 31,

2020

 

2019

 

2020

 

2019

 

Amount

 

Per
Diluted
Share

 

Amount

 

Per
Diluted
Share

 

Amount

 

Per
Diluted
Share

 

Amount

 

Per
Diluted
Share

Net income

$

34

 

 

$

0.56

 

 

$

168

 

 

$

2.67

 

 

$

673

 

 

$

11.23

 

 

$

737

 

 

$

11.47

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketplace risk corridor judgment

(128)

 

 

(2.15)

 

 

 

 

 

 

(128)

 

 

(2.14)

 

 

 

 

 

Acquisition-related expenses (1)

18

 

 

0.31

 

 

 

 

 

 

22

 

 

0.37

 

 

 

 

 

Amortization of intangible assets

4

 

 

0.07

 

 

4

 

 

0.06

 

 

16

 

 

0.26

 

 

17

 

 

0.27

 

Loss (gain) on debt repayment

10

 

 

0.18

 

 

 

 

 

 

15

 

 

0.26

 

 

(15)

 

 

(0.24)

 

Charitable contribution

15

 

 

0.25

 

 

 

 

 

 

15

 

 

0.25

 

 

 

 

 

Restructuring costs

1

 

 

0.01

 

 

1

 

 

0.02

 

 

10

 

 

0.16

 

 

6

 

 

0.10

 

Premium deficiency reserve - Puerto Rico

(4)

 

 

(0.07)

 

 

 

 

 

 

6

 

 

0.10

 

 

 

 

 

Subtotal, adjustments

(84)

 

 

(1.40)

 

 

5

 

 

0.08

 

 

(44)

 

 

(0.74)

 

 

8

 

 

0.13

 

Income tax effect

20

 

 

0.33

 

 

(1)

 

 

(0.02)

 

 

11

 

 

0.18

 

 

(2)

 

 

(0.03)

 

Adjustments, net of tax

(64)

 

 

(1.07)

 

 

4

 

 

0.06

 

 

(33)

 

 

(0.56)

 

 

6

 

 

0.10

 

Adjusted net (loss) income

$

(30)

 

 

$

(0.51)

 

 

$

172

 

 

$

2.73

 

 

$

640

 

 

$

10.67

 

 

$

743

 

 

$

11.57

 

__________________

(1) Beginning in the third quarter of 2020, reflects non-recurring costs associated with acquisitions, including various transaction and integration costs.

MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES CONTINUED

Normalized EPS represents adjusted EPS, as shown in the reconciliation of GAAP EPS to non-GAAP adjusted EPS, excluding the net effect of COVID. The net effect of COVID consists of discrete premium refunds, reduced demand for medical services, and the cost of COVID-related care. This non-GAAP financial measure should be considered a supplement to, and not a substitute for, GAAP earnings per diluted share. The Company believes this metric, which is used by management in the operation of the business, is helpful to investors in assessing the Company’s 2020 financial performance and operations without the temporary distortion caused by the COVID pandemic.

Normalized after-tax margin represents adjusted net income, excluding the net effect of COVID, divided by total revenue.

 

Three Months
Ended

 

Year Ended

 

December 31, 2020

 

 

 

 

 

(Per diluted share)

GAAP EPS – Diluted

$

0.56

 

 

$

11.23

 

Less: Adjustments, net of tax

(1.07)

 

 

(0.56)

 

Adjusted EPS – Diluted

(0.51)

 

 

10.67

 

Add: Net effect of COVID

3.80

 

 

2.30

 

Normalized EPS – Diluted

$

3.29

 

 

$

12.97

 

 

 

 

 

MOLINA HEALTHCARE, INC.

2021 GUIDANCE

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES

(In millions, except per diluted share amounts)

 

 

 

 

 

Low End

 

High End

 

Amount

 

Per
Diluted
Share (2)

 

Amount

 

Per
Diluted
Share (2)

Net income

$

649

 

 

$

11.10

 

 

$

678

 

 

$

11.60

 

Adjustments:

 

 

 

 

 

 

 

Acquisition-related expenses

62

 

 

1.06

 

 

62

 

 

1.06

 

Amortization of intangible assets

45

 

 

0.77

 

 

45

 

 

0.77

 

Subtotal, adjustments

107

 

 

1.83

 

 

107

 

 

1.83

 

Income tax effect (1)

(26)

 

 

(0.43)

 

 

(26)

 

 

(0.43)

 

Adjustments, net of tax

81

 

 

1.40

 

 

81

 

 

1.40

 

Adjusted net income

$

730

 

 

$

12.50

 

 

$

759

 

 

$

13.00

 

__________________

(1) Income tax effect calculated at the statutory tax rate of 23.9%.

(2) Computation assumes approximately 58.5 million diluted weighted average shares outstanding.

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.
Adjusted after-tax margin represents adjusted net income, divided by total revenue.

Contacts

Investor Contact: Julie Trudell, Julie.Trudell@molinahealthcare.com, 562-912-6720
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588

$Cashtags

Contacts

Investor Contact: Julie Trudell, Julie.Trudell@molinahealthcare.com, 562-912-6720
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588